Wang Laboratories v. Clearpoint Research Corp., 983 F.2d 1086 (Fed. Cir. 1992)

NOTICE: THIS IS AN UNPUBLISHED OPINION.

(The Court's decision is referenced in a “Table of Decisions Without Reported Opinions” appearing in the Federal Reporter. Use FI CTAF Rule 47.6 for rules regarding the citation of unpublished opinions.)
 

D.Mass.

VACATED.

*1 Clearpoint Research Corporation moves for a stay, pending appeal, of the preliminary injunction issued by the United States District Court for the District of Massachusetts on September 25, 1992. Wang Laboratories, Inc. opposes.

This matter stems from Wang's suit against Clearpoint for patent infringement of the claims of two of Wang's patents relating to single in-line memory modules (SIMMs). On September 25, 1992 the district court held a short hearing on Wang's motion for a preliminary injunction. At the hearing, each party was permitted to present one expert on the issue of infringement. ^FN* At the conclusion, the district court stated:

I have to make judgments about witnesses and the weight their testimony is to be given. In that regard, I have to consider their general credibility, reliability and objectivity. I don't make a great distinction between these two eminent scientists, these two engineers, but generally I must say that the testimony of Doctor Jeffery Frey [Wang's expert] impressed me more, probably because he has been better prepared.

A district court is required to set forth findings of fact and conclusions of law when granting or denying a motion for a preliminary injunction. Fed.R.Civ.P. 52(a). Sufficient findings and conclusions are necessary to allow an appellate court to have a basis for meaningful review. Nutrition 21 v. United States, 930 F.2d 867, 869 (Fed.Cir.1991); Digital Equipment Corp. v. Emulex Corp., 805 F.2d 380, 381 (Fed.Cir.1986). Here, the district court failed to set forth sufficient reasons for issuance of the injunction.

With regard to the applicability of the “presumption of irreparable harm” in the preliminary injunction context, this matter was recently addressed by the court in Nutrition 21, 930 F.2d at 871. The district court here stated that the presumption applied and failed to address the matter in view of Nutrition 21. Further, the district court was required to address the harm to Clearpoint. Indeed, on a motion to stay a preliminary injunction, pending appeal, one of the most important factors for this court to consider is irreparable harm to movant. See Standard Havens Products v. Gencor Industries, 897 F.2d 511 (Fed.Cir.1990). Finally, the district court's findings and conclusions with regard to likelihood of success were abbreviated and conclusory. Because of the failure of the district court to adequately set forth its reasons for issuance of the injunction, it is appropriate to vacate the injunction. Digital, 805 F.2d at 383.

*2 Accordingly,

IT IS ORDERED THAT:

(1) Clearpoint's motion for a stay is moot.

(2) The district court's September 25, 1992 injunction is vacated.

• Home
• Our Firm
• Mission
• Practice Areas
• Attorneys
• Articles / Opinions / Clients
  • Kelly v. Doukas, 64. Mass. App. Ct. 1113, 835 N.E.2d 1179 (2005)
  • McNichols v. Commissioner of Internal Revenue, 13 F.3d 432 (1st Cir. 1993)
  • Nally v. Volkswagen of America, Inc., 405 Mass. 191, 539 N.E.2d 1017 (1989)
  • PaineWebber v. Elahi, 87 F.3d 589 (1st Cir. 1996)
  • Richard Bertoli, et al. v. Sir Denis Malone as Cayman Authority - UK Privy Council (April 22, 1991
  • SEC v. Tome, 638 F. Supp. 596 (S.D.N.Y. 1986)
  • SEC v. Tome, 638 F. Supp. 629 (S.D.N.Y. 1986))
  • SEC v. Tome, 638 F. Supp. 638 (S.D.N.Y. 1986)
  • SEC v. Tome, 833 F.2d 1086 (2d Cir. 1987)
  • Sheehan v. North American Marketing Corp., 2008 WL 896152 (D.R.I. 2008)
  • Sheehan v. North American Marketing Corp., 610 F.3d 144 (1st Cir. 2010)
  • United States v. Cannistraro, 694 F. Supp. 62 (D.N.J. 1988)
  • United States v. Cannistraro, 871 F.2d 1210 (3d Cir. 1989)
  • United States v. Zolp, 659 F. Supp. 692 (D.N.J. 1987)
  • Wang Laboratories v. Clearpoint Research Corp., 5 F.3d 1504 (Fed. Cir. 1993)
  • Wang Laboratories v. Clearpoint Research Corp., 983 F.2d 1086 (Fed. Cir. 1992)
  • Sorkin & Giordano, "Civil Remedies Under RICO" in RICO: CIVIL AND CRIMINAL, (L.J. Sem. Pr. 1984)
  • Giordano, "Winning Strategies of a Chairman in Massachusetts" (PLI 1996)
• Legal Trends / Resources
• Contact